APA aipamena

Studebaker, A. W., Hutzen, B. J., Pierson, C. R., Haworth, K. B., Cripe, T. P., Jackson, E. M., & Leonard, J. R. (2017). Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors. Mol Ther Oncolytics.

Chicago Style aipamena

Studebaker, Adam W., Brian J. Hutzen, Christopher R. Pierson, Kellie B. Haworth, Timothy P. Cripe, Eric M. Jackson, and Jeffrey R. Leonard. "Oncolytic Herpes Virus RRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors." Mol Ther Oncolytics 2017.

MLA aipamena

Studebaker, Adam W., et al. "Oncolytic Herpes Virus RRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors." Mol Ther Oncolytics 2017.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.